Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence (2019)

First Author: Grüschow S

Attributed to: Cyclic oligoadenylate signalling - a new type of antiviral response funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/667758

Publication URI: http://dx.doi.org/10.1101/667758

Type: Preprint